AF
KALA icon

Amalgamated Financial’s KALA BIO KALA Stock Holding History

Amalgamated Financial’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$10K Buy
+3
New +$7.86K ﹤0.01% 2897

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Amalgamated Financial's KALA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in KALA BIO (KALA) in Q1 2022: 3 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #2897 among its holdings.

82 funds tracked by Wall St. Rank hold KALA as of Q1 2022.

  • Amalgamated Financial held 3 shares of KALA BIO worth $10K as of Q1 2022.
  • KALA BIO was a new Amalgamated Financial position in Q1 2022.
  • KALA BIO made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2897 holding.
  • 82 funds tracked by Wall St. Rank held KALA BIO as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.